Sydney Look-Why
MD Student
Boston University Chobanian & Avedisian School of Medicine



Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Chen SX, Wafae BGO, Look-Why S, Otto T, Snyder C, Sweet W, Ashina N, Gibson R, Salian P, Doroudian Tehrani M, Dervieux T, Kimball AB, Porter ML. Therapeutic drug monitoring of adalimumab in hidradenitis suppurativa: a prospective observational study. Front Immunol. 2026; 17:1760206. PMID: 41727443; PMCID: PMC12917758; DOI: 10.3389/fimmu.2026.1760206;
     
  2. Xiao B, Qian Z, Look-Why SL, Piccolini A, Dagnino F, Korn SM, Zurl H, Pohl KK, Stelzl DR, Wollin D, Trinh QD, Kibel AS, Cole AP. Prostate Biopsy and Malpractice: Analysis of a National Legal Database from 1995 to 2025. Urology. 2026 Feb; 208:117-123. PMID: 41418921
     
  3. Philip AM, Babiker F, Fernandez-Santos CC, Chikovsky MN, Dolinko AH, Ramezani K, Look-Why S, Manhapra A, Ruggeri ML, Chang PY, Foster S, Anesi SD. Characterisation of delayed severity flares in patients with HLA-B27-associated anterior uveitis. Br J Ophthalmol. 2025 Jan 28; 109(2):199-202. PMID: 39089846
     
  4. Look-Why SL, Kirimlishvili S, Porter ML, Kimball AB. Hidradenitis Suppurativa Epidemiology. Dermatol Clin. 2025 Apr; 43(2):145-154. PMID: 40023617
     
  5. Look-Why S, Goldberg J, Alexanian C, Rogers N, Coleman NNM, Lenzy YM, Pinos E, Goldberg LJ. Quantification of mast cells in central centrifugal cicatricial alopecia. JAAD Int. 2024 Jun; 15:38-43. PMID: 38371672; PMCID: PMC10869920; DOI: 10.1016/j.jdin.2023.11.008;
     
  6. Garcia CM, Maleki A, Look-Why S, Manhapra A, Durrani K, Foster CS. NONPARANEOPLASTIC AUTOIMMUNE RETINOPATHY VERSUS PERICENTRAL RETINAL DEGENERATION PHENOTYPE: WHICH CAME FIRST? A CASE REPORT. Retin Cases Brief Rep. 2023 Jul 01; 17(4):384-388. PMID: 34618714
     
  7. Maleki A, Colombo A, Look-Why S, Peter Y Chang BA, Anesi SD, Anesi SD. Rituximab Monotherapy versus Rituximab and Bortezomib Combination Therapy for Treatment of Non-paraneoplastic Autoimmune Retinopathy. J Ophthalmic Vis Res. 2022; 17(4):515-528. PMID: 36620716; PMCID: PMC9806323; DOI: 10.18502/jovr.v17i4.12304;
     
  8. Philip AM, Fernandez-Santos CC, Ramezani K, Dolinko AH, Manhapra A, Look-Why S, Chang PY, Foster CS, Anesi SD. Ocular Mucus Membrane Pemphigoid: A Primary Versus Secondary Entity. Cornea. 2023 Mar 01; 42(3):280-283. PMID: 36036657
     
  9. Maleki A, Ruggeri M, Colombo A, Asgari S, Look-Why S, Apoorva S, Foster CS. B-Scan Ultrasonography Findings in Unilateral Posterior Scleritis. J Curr Ophthalmol. 2022; 34(1):93-99. PMID: 35620365; PMCID: PMC9128424; DOI: 10.4103/joco.joco_267_21;
     
  10. Maleki A, Look-Why S, Manhapra A, Asgari S, Garcia CM, Al-Dabbagh A, Tsang C, Chang PY, Anesi SD, Foster CS. Birdshot Chorioretinopathy: Resistant versus Responsive. Ocul Immunol Inflamm. 2023 Apr; 31(3):477-482. PMID: 35353656
     
Showing 10 of 17 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 17 publications over 5 distinct years, with a maximum of 6 publications in 2021

YearPublications
20216
20225
20232
20253
20261

Contact for Mentoring:

Look-Why's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (65) concept(s)
_
Similar People
See all (60) people
_